drugset / Trial / NCT05317312
Study of MR-107A-02 in the Treatment of Post Surgical Dental Pain.
RandomizedParallel-groupDouble-blindTreatment
Summary
MR-107A-02 is being studied to investigate its efficacy, safety and dose-response after dental surgery.
Timeline
- Start
- 2022-03-31
- Primary completion
- 2022-06-15
- Completion
- 2022-06-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MR-107A-02 | Unknown | 1.25 mg | Oral |
| Subject | MR-107A-02 | Unknown | 5 mg | Oral |
| Subject | MR-107A-02 | Unknown | 15 mg | Oral |
Indications
No indication recorded.